• भारत सरकार के विज्ञान एवम प्रौदयोगिकी मंत्रालय के जैव प्रौदयोगिकी विभाग की स्वायत्त संस्थान
  • AN AUTONOMOUS INSTITUTE OF DEPT. OF BIOTECHNOLOGY, MINISTRY OF SCIENCE AND TECHNOLOGY, GOVT OF INDIA
  • होम
  • संकाय प्रोफ़ाइल
Publication

Corresponding Author

 

27) Das S@

Analysis of domain organization and functional signatures of trypanosomatid keIF4Gs.

 Molecular and Cellular Biochemistry 2022

26) Perween R, Kumar P, Srivastava T, Parray HA, Singh V, Singh S, Chiranjivi  A, Jakhar K, Sonar S, Tiwari M, Kumar R, Panchal AK, Sharma C, Rathore DK, Ahmed S, Samal

       S, Mani S, Bhattacharyya S, Das S, Luthra K, Kumar R

      The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41.

      International Immunopharmacology 2021 101(Pt B):108187.

25) Kumar R@, Ahmed S, Parray HA,Das S@ (@Co-corresponding authors)

     Chikungunya and arthritis: An overview. Review

     Travel Medicine and Infectious Disease 2021 44:102168.

24) Kumar P, Perween R, Shrivastava T, Singh V, Parray HA, Singh S, Chiranjivi A, Thiruvengadam R, Singh S, Yadav N, Jakhar K, Sonar S, Mani S, Bhattacharyya S, Sharma 

      C, Vishwakarma P, Khatri R, Panchal AK, Das S, Ahmed S, Samal S, Kshetrapal P, Bhatnagar S, Luthra K, Kumar R

       Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus.

       International Immunopharmacology 2021 99:108020. 

23) Das S@

      Taking a re-look at cap-binding signatures of the mRNA cap-binding protein eIF4E orthologues in trypanosomatids.

      Molecular and Cellular Biochemistry 2021 Review 476(2):1037-1049.

22) Das S@Kumar R, Ahmed S, Parray HA,Samal S

      Efficiently cleaved HIV-1 envelopes: Can they be important for vaccine immunogen design?

      Therapeutic Advances in Vaccines and Immunotherapy 2020; 8: 1-17. Review   

21) Ahmed S, Shrivastava T, Kumar R, Kumar M, Banerjee M, Kumar N, Bansal M,Das S, Samal S

      Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2 loop.

      Biochimica et Biophysica Acta – General Subjects 2020; 1865(1): 129733.

20) Samal S, Srivastava T,Sonkusre P, Rizvi ZA, Kumar R, Ahmed S, Viswakarma P, Yadav N,  Bansal M, Chauhan K, Pokhrel S, Das S, Tambare P, Awasthi A

      Tetramerizing tGCN4 Domain Facilitates Production of Influenza A H1N1 M2e Higher Order Soluble Oligomers that Show Enhanced Immunogenicity In vivo.

      J Biol Chem 2020, 295(42): 14352-14366.

19) Parray HA, Chiranjivi AK, Asthana S, Yadav N, Srivastava T, Mani S, Sharma C, Viswakarma P, Das S, Pindari K, Sinha S, Samal S, Ahmed S, Kumar R

      Identification of an anti-SARS-CoV-2 receptor binding domain (RBD) directed human monoclonal antibody from a naïve semi-synthetic library.

      J Biol Chem202095(36):12814-12821. 

18) Samal S, Bansal M, Das S@

      Method to identify efficiently cleaved, membrane-bound, functional HIV-1 (Human Immunodeficiency Virus-1) envelopes.

      MethodsX (Elsevier) 2019; 6:837-849.

17) Das S@, Bansal M, Bhattacharya J

      Characterization of the membrane-bound form of the chimeric, B/C recombinant HIV-1 Env, LT5.J4b12C. 

      J Gen Virol 2018; 99 (10): 1438-1443. 

16)  Samal S*, Das S*, Boliar S, Qureshi H, Shrivastava T, Kumar N, Goswami S, Bansal M, Chakrabarti BK (*Co-First Author)

       Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain  containing region in their C-

       terminal tail.

       Retrovirology 2018; 15:50.

15) Das S, Boliar S, Samal S, Ahmed S, Shrivastava T, Shukla BN, Goswami S, Bansal M, Chakrabarti BK

       Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with

       properties comparable to membrane-bound BG505.

       Virology 2017; 510:22-28.

14) Das S, Boliar S, Mitra N, Samal S, Bansal M, Koff WC, Chakrabarti BK

       Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly

       neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes.

       Retrovirology 2016; 13:81.

13) Boliar S*, Das S*, Bansal M, Shukla BN, Patil S, Shrivastava T, Samal S, Goswami S, King CR, Bhattacharya J, Chakrabarti BK (*Co-First Author)

      An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies.

      PLOS One 2015; 10(3): e0122443.         

12) Das S@

      Integrase interactor 1 in health and disease.

      Current Protein and Peptide Science 2015; 16(6):478-490. Review

11) Das S@Banerjee B, Hossain M, Thangamuniyandi M, Dasgupta S, Chongdar N, Kumar GS, Basu G

      Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).

      PLOS One 2013; 8(7): e66581.

10) Biswas A, Mukherjee S, Das S, Shields D, Chow CW, Maitra U.

      Opposing action of casein kinase 1 and calcineurin in nucleo-cytoplasmic shuttling of mammalian translation initiation factor eIF6.

      J Biol Chem 2011; 286(4):3129-3138.

9) Das S, Cano J, Kalpana GV.

    Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance.

    J Biol Chem 2009; 284(30):19903-19914.

8) Sorin M*, Cano J*, Das S, Mathew S, Wu X, Davies KP, Shi X, Cheng GS, Ott D, Kalpana GV.(*Equal Contribution)

    Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication.

    PLOS Pathogens 2009; 5(6) e1000463.

7)  Das S, Kalpana GV.

     Reverse Two-hybrid Screening to Analyze Protein-Protein Interaction of HIV-1 Viral and Cellular Proteins.

     Methods in Molecular Biology 2009; 485: 271-293.

6) Foletta VC, Lim MA, Soosairaiah J, Kelly AP, Stanley EG, Shannon M, He W, Das S,  Massague J, Bernard O.

    Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1.

    J Cell Biol 2003; 162(6):1089-1098.

5) Das S, Maitra U.

    Functional significance and mechanism of eIF5-promoted GTP hydrolysis in eukaryotic translation initiation.

    Prog Nucleic Acid Res Mol Biol 2001; 70:207-231. Review

4) Das S, Ghosh R, Maitra U.

    Eukaryotic translation initiation factor 5 functions as a GTPase-activating protein.
    J Biol Chem 2001; 276(9):6720-6726.

3)  Das S, Maitra U.

     Mutational analysis of mammalian translation initiation factor 5 (eIF5): role of interaction between the beta subunit of eIF2 and eIF5 in eIF5 function in vitro 

     and in vivo.
     Mol Cell Biol 2000; 20(11):3942-3950.

2) Maiti T*, Das S*, Maitra U. (*Co-First Author)

    Isolation and functional characterization of a temperature-sensitive mutant of the Yeast Saccharomyces cerevisiae in translation initiation factor eIF5: an eIF5-

    dependent cell-free translation system.
    Gene2000; 244(1-2):109-118.

1) Das S, Maiti T, Das K, Maitra U.

    Specific interaction of eukaryotic translation initiation factor 5 (eIF5) with the beta-subunit of eIF2.

    J Biol Chem 1997; 272(50):31712-31718. 

Corresponding Author

 

1) Recombinant construct, immunogenic composition against dengue virus and

     implementation thereof.

     Das S,Chiranjivi AK, Kumar CS, Parray HA, Ahmed S, Shrivastava T, Kumar R,

     Banerjee M

     (Provisional Indian Patent Filing No. 202111036849; 13/08/2021)

 

2) Native trimeric Env immunogen design

    Chakrabarti BK, Boliar S, Das S, Shrivastava T, King RC, Bhattacharya J, Samal S

    (US Patent: WO/2016/065252)

  • Translational Research Consortium for Establishing Platform Technologies to Support Prophylactic and Therapeutic Strategies for Dengue - Discovery to Proof-of-Concept (NBM-BIRAC, 2019-2023). Co-investigator
  • A next generation stabilized chikungunya virus (CHIKV) envelope-based soluble immunogen: Proof-of-concept (THSTI Intramural, 2021-2022). PI

Journal Advisory Board

Infectious Diseases and Therapy (2022-  )

 

Reviewer

PeerJ (2022-  )

Infectious Diseases and Therapy (2021-  )

Medicinal Chemistry (2020-  )

VirusDisease (2015-

Group Members

Anica Dadwal (Research Associate)

Ph.D University of Delhi

 

Abhay Deshmukh (M.Sc Trainee)

Yenepoya  Deemed To Be University, Mangalore

 

Former Group Members

Adarsh Chiranjivi (Research Associate)

Ph.D IIT, Guwahati

(Currently at University of Notre-Dame, USA)

 

M.Sc Trainees

Gaurav Kumar Singh (2020) 

Jamia Milia Islamia

M.Sc. Jamia Millia Islamia University, New Delhi

 

Kiran Sharma (2021) 

M.Sc Bansthali Vidyapith, Rajasthan

  • 9540278405
  • SUPRATIK[AT]THSTI[DOT]RES[DOT]IN